A share price of Caredx Inc [CDNA] is currently trading at $25.64, up 4.48%. An important factor to consider is whether the stock is rising or falling in short-term value. The CDNA shares have gain 10.85% over the last week, with a monthly amount glided 15.86%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Caredx Inc [NASDAQ: CDNA] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Underweight rating and assigned the stock a price target of $28. Previously, BTIG Research upgraded its rating to Buy on August 19, 2024, and kept the price target unchanged to $40. On May 13, 2024, downgrade downgraded it’s rating to Mkt Perform. Craig Hallum upgraded its rating to a Buy but stick to its price target of $15 on May 01, 2024. Stephens upgraded its rating to a Overweight but $10 remained the price target by the analyst firm on November 09, 2023. Raymond James upgraded its rating to Outperform for this stock on August 15, 2023, but kept the price target unchanged to $12. In a note dated May 11, 2023, BTIG Research downgraded an Neutral rating on this stock.
Caredx Inc experienced fluctuations in its stock price throughout the past year between $7.42 and $34.84. Currently, Wall Street analysts expect the stock to reach $29.75 within the next 12 months. Caredx Inc [NASDAQ: CDNA] shares were valued at $25.64 at the most recent close of the market. An investor can expect a potential return of 16.03% based on the average CDNA price forecast.
Analyzing the CDNA fundamentals
Trailing Twelve Months sales for Caredx Inc [NASDAQ:CDNA] were 312.77M which represents 23.35% growth. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at -0.18%, Pretax Profit Margin comes in at -0.46%, and Net Profit Margin reading is -0.46%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.54 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.72 points at the first support level, and at 23.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.16, and for the 2nd resistance point, it is at 26.68.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Caredx Inc [NASDAQ:CDNA] is 4.10. On the other hand, the Quick Ratio is 3.87, and the Cash Ratio is 1.17. Considering the valuation of this stock, the price to sales ratio is 4.33, the price to book ratio is 4.98.
Transactions by insiders
Recent insider trading involved PETER MAAG, Director, that happened on Nov 26 ’24 when 5000.0 shares were purchased. Officer, JEFFREY NOVACK completed a deal on Nov 25 ’24 to buy 1223.0 shares. Meanwhile, Officer JEFFREY NOVACK bought 5534.0 shares on Nov 18 ’24.
